Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-035170

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Climaco John M Director 2025-11-12 Grant or award · Stock Options (right to buy) +150,000 165,169 D
Loading xslF345X05/rdgdoc.xml…